[
  {
    "docId": "BSE-2025-09-01-ZESTRAL",
    "title": "Appointment of Independent Director",
    "company": "Zestral LLP",
    "filing_date": "2025-09-01",
    "source_url": "/demo/sample.pdf",
    "doc_sha256": "4b6851e3339893570c9764506ba5f6a9173f44383437531b7dfde9f7b0369796",
    "facts": {
      "action_type": "board_change",
      "fields": { "company_name": "Zestral LLP", "announcement_date": "2025-09-01", "change_type": "Appointment", "director_name": "Ms. Anya Sharma", "effective_date": "2025-09-01", "position": "Independent Director" },
      "evidence": { "director_name": { "page": 1, "quote": "appoint Ms. Anya Sharma (DIN: 01234567) as an Additional Director (Non-Executive Independent Director) of the Company" }, "effective_date": { "page": 1, "quote": "with effect from September 1, 2025" } },
      "risk_tags": ["governance"]
    },
    "bullets_en": [
      "Zestral LLP announced the appointment of Ms. Anya Sharma as an Independent Director.",
      "The appointment is effective from September 1, 2025.",
      "This change is part of a broader board restructuring initiative.",
      "Ms. Sharma brings over 15 years of experience in corporate governance.",
      "The company's stock remained stable following the announcement."
    ],
    "bullets_local": [
      "ज़ेस्ट्रल एलएलपी ने सुश्री अन्या शर्मा को एक स्वतंत्र निदेशक के रूप में नियुक्त करने की घोषणा की।",
      "यह नियुक्ति 1 सितंबर, 2025 से प्रभावी है।",
      "यह परिवर्तन एक व्यापक बोर्ड पुनर्गठन पहल का हिस्सा है।",
      "सुश्री शर्मा कॉर्पोरेट प्रशासन में 15 से अधिक वर्षों का अनुभव रखती हैं।",
      "घोषणा के बाद कंपनी का स्टॉक स्थिर रहा।"
    ],
    "generated_by": { "model": "V-Extractor-4.1-Turbo", "at": "2025-09-15T10:25:00Z" },
    "status": "published"
  },
  {
    "docId": "NSE-2025-08-12-RELIANCE-V1",
    "title": "Quarterly Results Q2 2025",
    "company": "Reliance Industries",
    "filing_date": "2025-08-12",
    "source_url": "https://www.bseindia.com/xml-data/corpfiling/AttachLive/...",
    "doc_sha256": "aaa...",
    "facts": { "action_type": "dividend", "fields": { "revenue": 25000, "profit": 5000, "dividend_per_share": 10 }, "evidence": { "dividend_per_share": { "page": 4, "quote": "a dividend of ₹10 per share" } }, "risk_tags": [] },
    "bullets_en": ["Revenue grew by 15% YoY.", "Declared a dividend of ₹10 per share."],
    "bullets_local": ["राजस्व में 15% की वार्षिक वृद्धि हुई।", "₹10 प्रति शेयर का लाभांश घोषित किया।"],
    "generated_by": { "model": "V-Extractor-4.0", "at": "2025-08-12T13:00:00Z" },
    "status": "published"
  },
    {
    "docId": "NSE-2025-08-12-RELIANCE-V2",
    "title": "REVISED: Quarterly Results Q2 2025",
    "company": "Reliance Industries",
    "filing_date": "2025-08-15",
    "source_url": "https://www.bseindia.com/xml-data/corpfiling/AttachLive/...",
    "doc_sha256": "bbb...",
    "facts": { "action_type": "dividend", "fields": { "revenue": 25000, "profit": 5250, "dividend_per_share": 10.5 }, "evidence": { "dividend_per_share": { "page": 4, "quote": "a revised dividend of ₹10.50 per share" } }, "risk_tags": [] },
    "bullets_en": ["Revenue grew by 15% YoY.", "Declared a revised dividend of ₹10.50 per share.", "Net profit corrected to ₹5250 crore."],
    "bullets_local": ["राजस्व में 15% की वार्षिक वृद्धि हुई।", "₹10.50 प्रति शेयर का संशोधित लाभांश घोषित किया।", "शुद्ध लाभ ₹5250 करोड़ पर संशोधित किया गया।"],
    "generated_by": { "model": "V-Extractor-4.0", "at": "2025-08-15T10:00:00Z" },
    "status": "published"
  },
  {
    "docId": "DRAFT-002",
    "title": "Board Meeting Outcome",
    "company": "Infotech Ltd.",
    "filing_date": "2025-09-10",
    "source_url": "https://www.bseindia.com/...",
    "doc_sha256": "ccc...",
    "facts": { "action_type": "board_change", "fields": {}, "evidence": {}, "risk_tags": [] },
    "bullets_en": [],
    "bullets_local": [],
    "generated_by": { "model": "V-Extractor-4.1-Turbo", "at": "2025-09-16T09:00:00Z" },
    "status": "draft"
  },
  {
    "docId": "DRAFT-003",
    "title": "Acquisition Announcement",
    "company": "PharmaCorp",
    "filing_date": "2025-09-11",
    "source_url": "https://www.bseindia.com/...",
    "doc_sha256": "ddd...",
    "facts": { "action_type": "buyback", "fields": { "acquired_company": "BioGen" }, "evidence": {}, "risk_tags": ["ma"] },
    "bullets_en": ["PharmaCorp to acquire BioGen for $500M.", "Deal expected to close in Q4 2025."],
    "bullets_local": ["फार्माकॉर्प $500M में बायोजेन का अधिग्रहण करेगी।", "सौदा 2025 की चौथी तिमाही में पूरा होने की उम्मीद है।"],
    "generated_by": { "model": "V-Extractor-4.1-Turbo", "at": "2025-09-16T10:00:00Z" },
    "status": "review"
  }
]